Maximus, Inc. (NYSE:MMS) – Analysts at First Analysis upped their Q1 2018 earnings estimates for Maximus in a report issued on Sunday. First Analysis analyst F. Sparacino now forecasts that the health services provider will post earnings per share of $0.78 for the quarter, up from their prior estimate of $0.77. First Analysis also issued estimates for Maximus’ Q2 2018 earnings at $0.75 EPS, Q3 2018 earnings at $0.71 EPS, Q4 2018 earnings at $0.76 EPS, FY2018 earnings at $3.00 EPS and FY2019 earnings at $3.31 EPS.

Other research analysts also recently issued reports about the stock. Zacks Investment Research downgraded shares of Maximus from a “hold” rating to a “sell” rating in a research report on Tuesday. BidaskClub cut shares of Maximus from a “hold” rating to a “sell” rating in a research note on Monday, July 24th. Robert W. Baird reiterated a “hold” rating and issued a $64.00 price target on shares of Maximus in a research note on Friday, September 1st. Maxim Group set a $66.00 target price on shares of Maximus and gave the company a “hold” rating in a research note on Thursday, August 3rd. Finally, Canaccord Genuity lowered their target price on shares of Maximus from $62.00 to $61.00 and set a “hold” rating on the stock in a research note on Friday. Two research analysts have rated the stock with a sell rating and seven have given a hold rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $63.00.

COPYRIGHT VIOLATION NOTICE: This article was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another publication, it was stolen and reposted in violation of US and international copyright law. The original version of this article can be viewed at https://www.americanbankingnews.com/2017/11/14/q1-2018-eps-estimates-for-maximus-inc-mms-lifted-by-first-analysis.html.

Maximus (NYSE MMS) opened at $64.63 on Tuesday. Maximus has a one year low of $51.74 and a one year high of $66.96. The company has a market cap of $4,089.63, a price-to-earnings ratio of 20.29, a P/E/G ratio of 1.99 and a beta of 1.32.

A number of institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its holdings in Maximus by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 5,669,026 shares of the health services provider’s stock worth $355,052,000 after acquiring an additional 130,839 shares in the last quarter. FMR LLC increased its holdings in Maximus by 10.4% in the 2nd quarter. FMR LLC now owns 4,658,584 shares of the health services provider’s stock worth $291,767,000 after acquiring an additional 438,025 shares in the last quarter. Victory Capital Management Inc. increased its holdings in Maximus by 13.3% in the 3rd quarter. Victory Capital Management Inc. now owns 3,514,228 shares of the health services provider’s stock worth $226,667,000 after acquiring an additional 413,325 shares in the last quarter. Janus Henderson Group PLC increased its holdings in Maximus by 718.8% in the 2nd quarter. Janus Henderson Group PLC now owns 2,211,638 shares of the health services provider’s stock worth $138,515,000 after acquiring an additional 1,941,521 shares in the last quarter. Finally, State Street Corp increased its holdings in Maximus by 3.5% in the 2nd quarter. State Street Corp now owns 2,138,049 shares of the health services provider’s stock worth $133,906,000 after acquiring an additional 71,823 shares in the last quarter. 97.55% of the stock is owned by institutional investors.

In other news, President Bruce Caswell sold 8,000 shares of the company’s stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $60.50, for a total transaction of $484,000.00. Following the completion of the sale, the president now owns 35,904 shares of the company’s stock, valued at approximately $2,172,192. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Richard A. Montoni sold 29,203 shares of the company’s stock in a transaction dated Thursday, August 17th. The shares were sold at an average price of $60.38, for a total transaction of $1,763,277.14. Following the sale, the chief executive officer now directly owns 549,215 shares of the company’s stock, valued at approximately $33,161,601.70. The disclosure for this sale can be found here. Insiders have sold a total of 137,103 shares of company stock valued at $8,503,210 in the last ninety days. Insiders own 3.10% of the company’s stock.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th will be given a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a dividend yield of 0.28%. The ex-dividend date of this dividend is Tuesday, November 14th. Maximus’s payout ratio is currently 5.66%.

Maximus Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Earnings History and Estimates for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.